Viewing data from:

AMPICILLIN AND SULBACTAM

ANDA

AMPICILLIN SODIUM; SULBACTAM SODIUM | A065074 | HIKMA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 19, 2002	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Mar 19, 2002

No patent or exclusivity listings for this strength.

#002 — EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Mar 19, 2002